Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycolic Acid SCHEMBL10706558 | 0.91 | ALDH1A1 (0.48) | ALDH1A1TSHRHTTLMNAMAPT | |
| SCHEMBL6680060 | 0.87 | ALDH1A1 (0.39) | ALDH1A1TSHRHTT | |
| SCHEMBL5703515 | 0.85 | ALDH1A1 (0.38) | ALDH1A1TSHRHTTLMNAMAPT | |
| SCHEMBL27625780 | 0.85 | ALDH1A1 (0.38) | ALDH1A1TSHRHTT | |
| SCHEMBL909920 | 0.85 | ALDH1A1 (0.61) | ALDH1A1TSHRLMNAMAPTKMT2A | |
| SCHEMBL19555034 | 0.82 | ALDH1A1 (0.39) | ALDH1A1TSHRHTTLMNAMAPT | |
| SCHEMBL21802019 | 0.79 | KMT2A (0.39) | ALDH1A1TSHRHTTMAPTKMT2A | |
| SCHEMBL7644387 | 0.79 | ALDH1A1 (0.37) | ALDH1A1TSHR | |
| SCHEMBL10608081 | 0.78 | — | — | |
| SCHEMBL27593689 | 0.78 | ALDH1A1 (0.43) | ALDH1A1TSHRHTTLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7268253-B2 | Process for preparing α, α-dialkyl-α-hydroxymethyl-carboxylic acid derivatives | CONSORTIUM FUER ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2007-09-11 | — | — | US | claimed |
| EP-1666447-B1 | Process for the preparation of alpha, alpha-dialkyl, alpha-hydroxymethyl-carboxylic acid derivatives | CONSORTIUM ELEKTROCHEM IND (DE) | 2007-02-14 | — | — | EP | claimed |
| US-20060122424-A1 | Process for preparing alpha, alpha-dialkyl-alpha-hydroxymethyl-carboxylic acid derivatives | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (US) | 2006-06-08 | — | — | US | claimed |
| US-4751120-A | CROSSLINKED POLYESTER COATING | TOYO SEIKAN KAISHA, LTD. (JP) | 1988-06-14 | — | — | US | claimed |
| EP-0114080-B1 | POLYMERIZABLE LIQUID COMPOSITION ADAPTED TO PRODUCE POLYMERS HAVING OUTSTANDING OPTICAL AND MECHANICAL PROPERTIES, POLYMERS AND ARTICLES OBTAINED WITH SAID COMPOSITION | ENICHEM SYNTHESIS S.p.A. (IT) | 1988-03-30 | — | — | EP | claimed |
| US-4687689-A | CROSSLINKING | TOYO SEIKAN KAISHA, LTD. (JP) | 1987-08-18 | — | — | US | claimed |
| EP-0114080-A1 | Polymerizable liquid composition adapted to produce polymers having outstanding optical and mechanical properties, polymers and articles obtained with said composition | ENICHEM SYNTHESIS S.p.A. (IT) | 1984-07-25 | — | — | EP | claimed |
| JP-10204158-A | — | — | None | — | — | JP | disclosed |
| JP-60031529-A | — | — | None | — | — | JP | disclosed |
| JP-2258790-A | — | — | None | — | — | JP | disclosed |
| EP-2282991-B1 | METHOD FOR THE PRODUCTION OF 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2018-01-24 | — | — | EP | disclosed |
| US-20160213891-A1 | Medical Dilation Element | ZAMORE, ALAN | 2016-07-28 | — | — | US | disclosed |
| US-9333278-B2 | Medical dilation element | Medtech Capital Ventures LLC (US) | 2016-05-10 | — | — | US | disclosed |
| US-4687689-A | CROSSLINKING | TOYO SEIKAN KAISHA, LTD. (JP) | 1987-08-18 | — | — | US | disclosed |
| JP-S6031529-A | MODIFIED POLYSTYRENE RESIN COMPOSITION OR MOLDING | NISSIN ELECTRIC CO LTD | 1985-02-18 | — | — | JP | disclosed |
| US-4383903-A | POLYFUNCTIONAL AROMATIC CYANATE, ACRYLIC COMPOUND, POLYFUNCTIONAL MALEIMIDE, PHOTOINITIATOR | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1983-05-17 | — | — | US | disclosed |
| US-4297099-A | BY PENETRATION AND CROSSLINKING | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1981-10-27 | — | — | US | disclosed |
| US-4001368-A | CURING | DAI NIPPON TORYO CO., LTD. (JA) | 1977-01-04 | — | — | US | disclosed |
| US-3968316-A | Process for the surface treatment of unsaturated rubber | NIPPON ZEON CO., LTD. (JA) | 1976-07-06 | — | — | US | disclosed |
| JP-S0631529-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122424-A1 | Process for preparing alpha, alpha-dialkyl-alpha-hydroxymethyl-carboxylic acid derivatives | DDC, ADH1C, MCCC2 | ALDH1A1 32/4885TSHR 4475/4885HTT 1432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.